XenoPort, Inc. (Nasdaq: XNPT) announced today that it will release its
first quarter financial results on April 24, 2013 at approximately 4:30
p.m. Eastern Time. The company will host a conference call at 5:00 p.m.
Eastern Time that same day. A replay of the call will be available for
one week following the event.
To access the conference call via the Internet, go to www.XenoPort.com.
Please join the call at least 15 minutes prior to the start to ensure
time for any software downloads that may be required.
To access the live conference call via phone, dial 1-888-275-3514.
International callers may access the live call by dialing 706-679-1417.
The reference number to enter the call is 46125297.
The replay of the conference call may be accessed that same day after
8:00 p.m. Eastern Time, via the Internet, at www.XenoPort.com,
or via phone at 1-855-859-2056 for domestic callers, or 404-537-3406 for
international callers. The reference number to enter the replay of the
call is 46125297.
About XenoPort
XenoPort is a biopharmaceutical company focused on developing and
commercializing a portfolio of internally discovered product candidates
for the potential treatment of neurological disorders. Horizant®
(gabapentin enacarbil) Extended-Release Tablets is our first
approved product in the United States. GlaxoSmithKline holds
commercialization rights for Horizant in the United States during
a transition period ending on April 30, 2013, following which XenoPort
will be responsible for the further development, manufacturing and
commercialization of Horizant. Regnite® (gabapentin
enacarbil) Extended-Release Tablets is approved and is being marketed in
Japan. Astellas Pharma Inc. holds all development and commercialization
rights for Regnite in Japan and five other Asian countries.
XenoPort holds all other world-wide rights to gabapentin enacarbil.
XenoPort's pipeline of product candidates includes potential treatments
for patients with spasticity, Parkinson's disease, relapsing-remitting
multiple sclerosis and psoriasis. To learn more about XenoPort, please
visit the web site at www.XenoPort.com.
XENOPORT, Horizant and Regnite are registered trademarks
of XenoPort, Inc.
XNPT2F
